Group Daiichi Sankyo Company, Limited

Stock

Market Closed - Japan Exchange Other stock markets 12:00:00 15/05/2026 pm IST			5-day change	1st Jan Change
2,574.00 ^JPY	-0.31%		-0.85%	-23.12%

16/05	Astrazeneca and Daiichi Sankyo Receive Us Approval for Enhertu for Two New Indications in Her2-Positive Early Breast Cancer	CI
16/05	FDA approves Daiichi Sankyo's fam-trastuzumab deruxtecan-nxki for two breast cancer indications	RE

Company	Manager
Daiichi Sankyo Europe GmbH Daiichi Sankyo Europe GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Masahiro Kato